NeoPharm Announces Execution of a Letter of Intent with SIRO ClinPharm for a planned Confirmatory...
                   
yahoo.com     May 22, 2008            

LAKE BLUFF, Ill.--(BUSINESS WIRE)--NeoPharm, Inc. (NASDAQ: NEOL - News ) today announced that it has signed a letter of intent with SIRO ClinPharm USA (“SIRO”) with regard to SIRO’s engagement to oversee a planned confirmatory Phase III trial for its drug product candidate Cintredekin Besudotox... [read full story]                

Add a comment to the article
Type the code shown

View all news articles about:

- Related Topics

View other selected articles:

                   

Go with your gut

azstarnet.com     1 mins ago          

In today's uncertain economy, it can't hurt to make your next meal an all-you-can-eat extravaganza. Whether it's Indian, Italian, Asian, Mexican or American, many Tucson restaurants have buffets or feature all-you-can-eat...                

comments

TruePosition Expands R and D On Location-Based Safety And Security Solutions

spacedaily.com     1 hr ago          

Boston MA (SPX) Jul 24, 2008 - TruePosition has announced the worldwide expansion of its research and development initiatives and the opening of a world-class Research and Development Center in Westborough, Massachusetts. The...                

comments

                   

Techno valley project takes off in Riyadh

menafn.com     2 hrs ago   1 related          

King Saud University (KSU) in Riyadh has crossed a new milestone in its efforts to develop a knowledge society with the launch of its Riyadh Techno Valley (RTV) project. Acting Riyadh Gov. Prince Sattam laid the foundation...                

comments

                   

Fort plan calls for town center for Tinton Falls

gmnews.com     3 hrs ago   3 related          

Panel holds first of four presentations on fort reuse plan TINTON FALLS - The final reuse draft plan for Fort Monmouth was presented to borough residents and officials in the first of four public hearings to take place before...                

comments